Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7905)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2018 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori. World J Gastrointest Oncol 2018; 10(5): 115-123 [PMID: 29770171 DOI: 10.4251/wjgo.v10.i5.115] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v10/i5/115.htm |
| Number | Citing Articles |
| 1 |
Liting Xi, Jinzhou Zhu, Huixian Zhang, Merlin Muktiali, Chunfang Xu, Airong Wu. Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study. Digestive Diseases and Sciences 2019; 64(2): 532 doi: 10.1007/s10620-018-5335-6
|
| 2 |
Seungkyung Kang, Soo-Jeong Cho. Proton Pump Inhibitors and Gastric Cancer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(3): 173 doi: 10.7704/kjhugr.2021.0010
|
| 3 |
Li-Ping Liu, Xi-Ping Sheng, Tian-Kui Shuai, Yong-Xun Zhao, Bin Li, Yu-Min Li. <i>Helicobacter pylori</i> promotes invasion and metastasis of gastric cancer by enhancing heparanase expression. World Journal of Gastroenterology 2018; 24(40): 4565-4577 doi: 10.3748/wjg.v24.i40.4565
|
| 4 |
M A Livzan. Underwater rocks of anti - helicobacter therapy. Terapevticheskii arkhiv 2019; 91(8): 141 doi: 10.26442/00403660.2019.08.000386
|
| 5 |
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Ka-Shing Cheung, Chung-Wah Siu. Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. BMJ Open Gastroenterology 2021; 8(1): e000719 doi: 10.1136/bmjgast-2021-000719
|
| 6 |
Wing Sum Shin, Fuda Xie, Bonan Chen, Peiyao Yu, Jun Yu, Ka Fai To, Wei Kang. Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge. Cancers 2023; 15(9): 2639 doi: 10.3390/cancers15092639
|
| 7 |
Yiwen Wang, Wenjie Han, Na Wang, Mengzhen Han, Meng Ban, Jianying Dai, Yuesheng Dong, Tao Sun, Junnan Xu. The role of microbiota in the development and treatment of gastric cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1224669
|
| 8 |
Yuan Liu, Haolang Wen, Qiao Wang, Shiyu Du. Research trends in endoscopic applications in early gastric cancer: A bibliometric analysis of studies published from 2012 to 2022. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1124498
|
| 9 |
Ankita Punetha, Arun Kumar Punetha. Microbiome Therapeutics. 2023; : 197 doi: 10.1016/B978-0-323-99336-4.00012-4
|
| 10 |
Zhoukai Zhao, Ruopeng Zhang, Guoming Chen, Man Nie, Feiyang Zhang, Xiaojiang Chen, Jun Lin, Zewei Chen, Feizhi Lin, Chengzhi Wei, Ziqi Zheng, Shenghang Ruan, Bowen Huang, Yingbo Chen, Runcong Nie. Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy. JAMA Network Open 2024; 7(3): e243812 doi: 10.1001/jamanetworkopen.2024.3812
|
| 11 |
Maria A. Livzan, Sergei I. Mozgovoi, Olga V. Gaus, Anna G. Shimanskaya, Alexei V. Kononov. Histopathological Evaluation of Gastric Mucosal Atrophy for Predicting Gastric Cancer Risk: Problems and Solutions. Diagnostics 2023; 13(15): 2478 doi: 10.3390/diagnostics13152478
|
| 12 |
Hang Yang, Liwen Guan, Bing Hu, Leticia Moreira. Detection and Treatment of Helicobacter pylori: Problems and Advances. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/4710964
|
| 13 |
Ka Shing Cheung, Wai K. Leung. Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence. Therapeutic Advances in Gastroenterology 2019; 12: 175628481983451 doi: 10.1177/1756284819834511
|
| 14 |
Huiqin Gao, Lunan Li, Ke Geng, Changzheng Teng, Yuanyuan Chen, Fei Chu, Yi Zhao. Use of proton pump inhibitors for the risk of gastric cancer. Medicine 2022; 101(49): e32228 doi: 10.1097/MD.0000000000032228
|
| 15 |
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>. Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
|
| 16 |
Amir Abbas Hamidi, Mohammad Mahdi Forghanifard, Mehran Gholamin, Meysam Moghbeli, Bahram Memar, Ali Jangjoo, Mohammad Reza Motie, Fatemeh Molaei, Mohammad Reza Abbaszadegan. Elucidated tumorigenic role of MAML1 and TWIST1 in gastric cancer is associated with Helicobacter pylori infection. Microbial Pathogenesis 2022; 162: 105304 doi: 10.1016/j.micpath.2021.105304
|
| 17 |
Tao Lyu, Ka Shing Cheung, Li Ni, Jiaqi Guo, Pei Mu, Yinpeng Li, Qiu Yang, Xiqiu Yu, Zhiwu Lyu, Jianwei Wu, Haijian Guo, Wai K Leung, Wai-Kay Seto. High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study. Journal of Antimicrobial Chemotherapy 2020; 75(11): 3391 doi: 10.1093/jac/dkaa315
|
| 18 |
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar. Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut 2022; 71(9): 1724 doi: 10.1136/gutjnl-2022-327745
|
| 19 |
You Wu, Tun Su, Xianzhu Zhou, Nonghua Lu, Zhaoshen Li, Yiqi Du. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross‐sectional survey. Helicobacter 2020; 25(4) doi: 10.1111/hel.12705
|
| 20 |
Ka Shing Cheung, Kit Lam Chung, Wai K. Leung. Chemopreventive Effect of Metformin on Gastric Cancer Development. Gut and Liver 2022; 16(2): 147 doi: 10.5009/gnl210132
|
| 21 |
Ka-Shing Cheung, Wai K Leung, Wai-Kay Seto. Application of Big Data analysis in gastrointestinal research. World Journal of Gastroenterology 2019; 25(24): 2990-3008 doi: 10.3748/wjg.v25.i24.2990
|
| 22 |
Chin-Hsiao Tseng. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 2021; 11(7): 1022 doi: 10.3390/biom11071022
|
| 23 |
Ho-Yu Ng, Wai K. Leung, Ka-Shing Cheung. Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection. International Journal of Molecular Sciences 2023; 24(14): 11708 doi: 10.3390/ijms241411708
|
| 24 |
M. A. Livzan, O. V. Gaus, M. A. Lisovskiy, S. I. Mozgovoi, V. A. Rubtsov, M. N. Parygina. Clinical supervision of chronic atrophic gastritis. Experimental and Clinical Gastroenterology 2023; (3): 148 doi: 10.31146/1682-8658-ecg-211-3-148-155
|
| 25 |
V.I. Petrov, A.V. Ponomareva, I.V. Ivakhnenko, O.V. Razvalyaeva, A.M. Dotsenko. PROBLEMS OF ERADICATION THERAPY AND WAYSTO OVERCOME THEM: REVIEW OF MODERN RECOMMENDATIONS AND REAL PRACTICE. Journal of Volgograd State Medical University 2022; 19(4): 22 doi: 10.19163/1994-9480-2022-19-4-22-33
|
| 26 |
Manami Inoue, Norie Sawada, Atsushi Goto, Taichi Shimazu, Taiki Yamaji, Motoki Iwasaki, Shoichiro Tsugane. High-Negative Anti–Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(2): 420 doi: 10.1158/1055-9965.EPI-19-0993
|
| 27 |
Chengliang Zhou, Tanya M. Bisseling, Rachel S. van der Post, Annemarie Boleij. The influence of Helicobacter pylori, proton pump inhibitor, and obesity on the gastric microbiome in relation to gastric cancer development. Computational and Structural Biotechnology Journal 2024; 23: 186 doi: 10.1016/j.csbj.2023.11.053
|
| 28 |
Bofei Li, Ka Shing Cheung, Ian Yu‐Hong Wong, Wai Keung Leung, Simon Law. Calcium channel blockers are associated with lower gastric cancer risk: A territory‐wide study with propensity score analysis. International Journal of Cancer 2021; 148(9): 2148 doi: 10.1002/ijc.33379
|
| 29 |
Monika Laszkowska, Aaron Oh, Chin Hur. Screening for Upper Gastrointestinal Malignancies in the United States—Which Immigrant Groups Should Be Considered High-Risk?. Gastroenterology 2020; 158(1): 4 doi: 10.1053/j.gastro.2019.09.047
|
| 30 |
Wai K. Leung, Ka Shing Cheung, Bofei Li, Simon Y. K. Law, Thomas K. L. Lui. Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2021; 53(8): 864 doi: 10.1111/apt.16272
|
| 31 |
Jiro Watari, Chiyomi Ito, Tadakazu Shimoda, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Kiron M. Das, Hiroto Miwa. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin use. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49069-1
|
| 32 |
D. S. Bordin, M. A. Livzan, M. F. Osipenko, S. I. Mozgovoy, D. N. Andreyev, I. V. Maev. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology 2022; (9): 5 doi: 10.31146/1682-8658-ecg-205-9-5-21
|
| 33 |
Chino Iizuka, Soichiro Sue, Sho Onodera, Aya Ikeda, Ryosuke Ikeda, Yoshihiro Goda, Kuniyasu Irie, Hiroaki Kaneko, Shin Maeda. Risk assessment of metachronous gastric cancer after endoscopic submucosal dissection based on endoscopic intestinal metaplasia. JGH Open 2023; 7(11): 783 doi: 10.1002/jgh3.12989
|
| 34 |
Subhajit Mukherjee, Souvik Ghatak, Lalhma Chhuani, Benjamin Lalrinpuia, Lalrin Jahau, Jeremy L. Pautu, Madhurjya Sarmah, Nachimuthu Senthil Kumar. Helicobacter pylori virulent genes and host interleukin 1 are associated with demographic factors for an increased risk of gastritis. Human Gene 2022; 34: 201132 doi: 10.1016/j.humgen.2022.201132
|
| 35 |
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, Christoph K. Stein-Thoeringer, Eran Elinav. Microbiome and cancer. Cancer Cell 2021; 39(10): 1317 doi: 10.1016/j.ccell.2021.08.006
|
| 36 |
Alexios-Fotios A. Mentis, Efthimios Dardiotis. Helicobacter pylori Eradication for Metachronous Gastric Cancer: An Unsuitable Methodology Impeding Broader Clinical Usage. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00090
|
| 37 |
Magdalena Dzikowiec, Dorota Pastuszak-Lewandoska. The uninvited guests of our microbiome: Helicobacter pylori and Epstein-Barr virus and their role in gastric cancerogenesis. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 611 doi: 10.2478/ahem-2021-0008
|
| 38 |
Ka Shing Cheung, Wai K. Leung. Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication. Oncotarget 2018; 9(97): 36891 doi: 10.18632/oncotarget.26382
|
| 39 |
Yu-Lan Gao, Yue-Han Zhang. Gastric cancer prevention targeted on risk assessment: the Kyoto Classification of Gastritis. 2021 11th International Conference on Information Technology in Medicine and Education (ITME) 2021; : 330 doi: 10.1109/ITME53901.2021.00074
|
| 40 |
I. N. Voynovan, Yu. V. Embutnieks, D. V. Mareeva, S. V. Kolbasnikov, D. S. Bordin. Helicobacter pylori as a risk factor for gastric cancer: the evidence and primary prevention strategy. Almanac of Clinical Medicine 2019; 47(6): 535 doi: 10.18786/2072-0505-2019-47-052
|
| 41 |
Jun-Hyung Cho, So-Young Jin. Optimized diagnosis of Helicobacter pylori and tailored eradication therapy for preventing gastric cancer: a proposal for SHAKE strategy. Expert Review of Gastroenterology & Hepatology 2020; 14(7): 553 doi: 10.1080/17474124.2020.1770594
|
| 42 |
Ka Shing Cheung, Esther W. Chan, Lijia Chen, Wai Kay Seto, Ian C.K. Wong, Wai K. Leung. Diabetes Increases Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study With Propensity Score Analysis. Diabetes Care 2019; 42(9): 1769 doi: 10.2337/dc19-0437
|
| 43 |
M. A. Livzan, O. V. Gaus, S. I. Mozgovoi. Gastric cancer in a patient with chronic gastritis after <i>H. pylori</i> eradication: assessing the risks. Experimental and Clinical Gastroenterology 2022; (9): 22 doi: 10.31146/1682-8658-ecg-205-9-22-28
|
| 44 |
Anca Negovan, Ioan Țilea, Septimiu Voidăzan, Simona Mocan, Andreea Szoke, Andreea Stoica, Monica Pantea. Chronic Statin Therapy and Histologic Gastric Changes. Journal of Interdisciplinary Medicine 2018; 3(4): 221 doi: 10.2478/jim-2018-0039
|
| 45 |
Seung In Seo, Chan Hyuk Park, Seng Chan You, Jae Young Kim, Kyung Joo Lee, Jinseob Kim, Yerim Kim, Jong Jin Yoo, Won-Woo Seo, Hyung Seok Lee, Woon Geon Shin. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 2021; 70(11): 2066 doi: 10.1136/gutjnl-2020-323845
|
| 46 |
Ka Shing Cheung, Esther W. Chan, Angel Y.S. Wong, Lijia Chen, Wai-Kay Seto, Ian C.K. Wong, Wai K. Leung. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Helicobacter Pylori Infection: A Territory-Wide Propensity Score Matched Study. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(2): 493 doi: 10.1158/1055-9965.EPI-19-1044
|
| 47 |
Yifat Snir, Haim Leibovitzh, Yaara Leibovici‐Weissman, Alex Vilkin, Arnon D. Cohen, Tzippy Shochat, Yaron Niv, Iris Dotan, Ilan Feldhamer, Doron Boltin, Zohar Levi. Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients. United European Gastroenterology Journal 2021; 9(3): 343 doi: 10.1177/2050640620951403
|
| 48 |
Hang Yang, Yi Mou, Bing Hu. Discussion on the common controversies of Helicobacter pylori infection. Helicobacter 2023; 28(1) doi: 10.1111/hel.12938
|
| 49 |
Yuan Qin, Jia-Xin Geng, Biao Huang. Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases. World Journal of Gastrointestinal Oncology 2023; 15(7): 1174-1181 doi: 10.4251/wjgo.v15.i7.1174
Abstract(203) |
Core Tip(239) |
Full Article(HTML)(1358)
|
Full Article with Cover (PDF)-1057K(41)
|
Full Article (Word)-402K(94)
|
Audio-13016K(3)
|
Peer-Review Report-321K(22)
|
Answering Reviewers-217K(26)
|
Full Article (PDF)-846K(105)
|
Full Article (XML)-129K(47)
|
Times Cited (2)
|
Total Visits (2769)
|
Open
|
| 50 |
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, Federica Grillo, Paola Parente, Sara Lonardi, Claudio Luchini, Filippo Pietrantonio, Clara Ugolini, Alessandro Vanoli, Matteo Fassan. Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion. Pathology - Research and Practice 2024; 254: 155145 doi: 10.1016/j.prp.2024.155145
|
| 51 |
Bofei Li, Ka Shing Cheung, Ian Yu‐Hong Wong, Wai Keung Leung, Simon Law. Nonaspirin nonsteroidal anti‐inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory‐wide study. Cancer 2021; 127(11): 1805 doi: 10.1002/cncr.33412
|
| 52 |
Ka Shing Cheung, Esther W Chan, Angel Y S Wong, Lijia Chen, Wai Kay Seto, Ian C K Wong, Wai K Leung. Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication. JNCI: Journal of the National Cancer Institute 2019; 111(5): 484 doi: 10.1093/jnci/djy144
|